SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-005282
Filing Date
2012-01-31
Accepted
2012-01-31 10:01:32
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-31049_110q.htm 10-Q 645225
2 EX-31.1 a11-31049_1ex31d1.htm EX-31.1 13006
3 EX-31.2 a11-31049_1ex31d2.htm EX-31.2 13458
4 EX-32 a11-31049_1ex32.htm EX-32 7827
  Complete submission text file 0001104659-12-005282.txt   2241837

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT imgn-20111231.xml EX-101.INS 244522
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgn-20111231.xsd EX-101.SCH 8680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgn-20111231_cal.xml EX-101.CAL 37471
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgn-20111231_def.xml EX-101.DEF 55497
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT imgn-20111231_lab.xml EX-101.LAB 173025
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgn-20111231_pre.xml EX-101.PRE 83691
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 12557684
SIC: 2834 Pharmaceutical Preparations